AstraZeneca
-
J&J’s COVID-19 vaccine restricted by FDA due to rare but serious blood clot riskU.S. regulators on Thursday strictly limited who can receive Johnson & Johnson's COVID-19 vaccine due to the ongoing risk of rare but serious blood clots.HealthMay 5
-
COVID-19: Booster shot uptake rises in Sask. as province adds 829 new cases, 14 deathsThere were 829 new COVID-19 cases confirmed last week in Saskatchewan with 231 cases found in the Saskatoon zone and 141 in the Regina zone.HealthApr 28
-
-
Advertisement
-
Health Canada OKs AstraZeneca’s Evusheld drug for COVID-19 preventionAstraZeneca's Evusheld contains lab-made antibodies designed to linger in the body for months to contain the virus in case of an infection.CanadaApr 14
-
-
Advertisement
-
AstraZeneca forecasts 2022 growth even as COVID revenue wanesWhile sales of COVID-19 products are expected to decline by a low-to-mid 20s percentage this year, Astrazeneca forecast overall revenues to rise by a high teens percentage.ConsumerFeb 10
-
AstraZeneca says it is working on an Omicron vaccine with Oxford"Together with Oxford University, we have taken preliminary steps in producing an Omicron variant vaccine, in case it is needed," a spokesperson for the company said.WorldDec 21, 2021
-
-
FDA approves 1st COVID-19 antibody drug intended for long-term preventionPeople who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs.WorldDec 8, 2021
-
-
Omicron variant: AstraZeneca exploring impact on vaccine, antibody cocktailAstraZeneca said that it had developed a vaccine platform to respond quickly to new variants with Oxford University, where its vaccine was created.WorldNov 26, 2021
-
AstraZeneca says COVID-19 antibody drug 83% effective over six monthsAstraZeneca's treatment is given in one go, as two sequential shots in the arm.HealthNov 18, 2021
-
-
Advertisement
-
Federal funding to aid expansion of Hamilton-based lab studying vaccine-related blood clotsDuring the pandemic, the McMaster Platelet Immunology Laboratory (MPIL) has been studying VITT – an affliction identified in some COVID-19 vaccine recipients.HealthNov 10, 2021
-
-
Advertisement
-
COVID-19: Booster shot eligibility opens for some Ontario at risk groups todayStarting today, those who are aged 70 and older, health-care workers, essential caregivers in congregate settings, and adults in Indigenous communities can book an appointment.HealthNov 6, 2021
Trending
-
Monkeypox: Here are the treatments and what to do when infected3161 Read
-
At least 2 dead, over 300,000 without power after severe Ontario thunderstorm2714 Read
-
Canada now has 10 confirmed cases of severe hepatitis in kids. Here’s what to watch for1971 Read
-
Canada, other nations stage walkout at APEC meeting over Russia’s war on Ukraine1515 Read
-
3 more monkeypox cases confirmed in Quebec, bringing Canadian total to 51226 Read
-
Toronto probing 1st suspected case of monkeypox1081 Read
-
Top Videos
-
At least 2 dead after severe storm hits Ontario3572 Viewed
-
Scientists trying to identify origins of Monkeypox cases detected in Canada2844 Viewed
-
Mysterious hepatitis cases in children reported in Canada1032 Viewed
-
Fact or Fiction: Abortion misinformation spikes following Roe v Wade leak, data shows957 Viewed
-
Breastfeeding B.C. mom saves pet goose from eagle attack899 Viewed
-
Russia-Ukraine conflict: Biden says Putin’s ‘brutal war’ highlights need to protect supply chains744 Viewed
-